Seroquel's Connection To Diabetes Is Questioned In New Data Documents
The FDA had concerns about new antipsychotic drugs shortly after they came on the market in the 1990s. According to this article in the Philadelphia Inquirer, the agency was worried they might trigger diabetes in some patients.
In 2000, the FDA asked AstraZeneca P.L.C. to share data on cases of new-onset diabetes and related illnesses in patients taking the antipsychotic drugs. AstraZeneca told the FDA that patients and doctors had reported 12 new cases of diabetes and five cases of related illnesses among the 623,000 who had taken its drug Seroquel.
However, court documents showed that the company had reported the number as 27 cases of diabetes and two of hyperglycemia.
The article stated that these documents surfaced in lawsuits filed in Orlando, Florida. The suits were filed by patients who claimed taking Seroquel caused their diabetes. Last month, the FDA required AstraZeneca to make information about Seroquel and weight gain more prominent on the drug’s label.
In 2000 AstraZeneca told the FDA it was “unlikely” that taking Seroquel led to diabetes.
A lawyer who wrote the document for plaintiff firm said AstraZeneca should have reported the larger number.
Documents released last week contained AstraZeneca e-mails in which employees discussed “buried” studies showing connections between Seroquel and weight gain.
AstraZeneca faces personal-injury claims from about 15,000 people who took Seroquel and say it caused diabetes.
If you or a loved one has suffered adverse reactions from taking Seroquel and would like to be kept informed about the most recent developments, news, or to discuss your legal options, please call Cherry, Fieger, and Marciano.
People of all ages take prescription drugs, non-prescription drugs, and supplements on a daily basis in the United States to prevent and treat various illnesses. Although these medications are supposed to help people, many people have suffered serious side effects, and even death.
If you or a loved one has been injured as the result of a dangerous drug reaction in Pennsylvania, the skilled Pennsylvania pharmaceutical drug litigation attorneys at Cherry, Fieger, and Marciano, LLP may be able to help you recover the monetary compensation that you deserve.
If a manufacturer produces drugs or supplements that are defective, they can and should be held responsible for the injuries they cause. As a manufacturer of pharmaceuticals, the company has an obligation to make a safe product, which includes various aspects such as thoroughly inspecting the product and affixing an appropriate label on the packaging. It is extremely important that you hire a skilled Philadelphia defective product lawyer to prove that the manufacturer was responsible for producing an unsafe product, as this is a very complicated and difficult part of the case.
It is essential to have representation on your side that has extensive experience representing people in similar matters. Contact Cherry Fieger and Marciano, LLP today for a free consultation.